France Cannabis Pilot Extended to 2027 | Medical Access Delayed | Hanf Magazin
France medical cannabis pilot 2027 extension provides crucial data on regulatory challenges. The delay in medical access underscores complexities in establishing evidence-based frameworks. This extension reflects cautious progress in conservative…
Our Opinion: PA needs to get on board with legalized recreational marijuana
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient…
Downturn in medicinal cannabis prescriptions – RACGP
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Access BarriersHealthcare PolicyPrescribing…
Sentencing Set for Former Officers in Humboldt Cannabis Theft Case
Law enforcement cannabis misconduct is undermining patient trust in medical cannabis programs. Sentencing for two former Rohnert Park officers is set for May 6 related to cannabis theft. This case highlights challenges within the cannabis regulatory…
New Zealand: Nascent Medical Cannabis Industry Aims for Growth
The new zealand medical cannabis industry is expanding with a focus on pharmaceutical-grade products and strict regulatory standards. This growth highlights New Zealand's unique healthcare integration approach. Monitoring this industry offers valuable…
Australia’s Medical Cannabis Regulation at Eight Years: Rapid Growth, Persistent Gaps
Australian medical cannabis regulation has seen rapid growth from 2016 to 2024, with prescriptions rising dramatically. Despite this, persistent gaps remain in cost, access, and prescriber education. This review highlights key challenges and lessons from…
Number of Hampshire Residents Prescribed Medical Cannabis Passes 3000
Medical cannabis prescription data highlights Hampshire's milestone of surpassing 3,000 patients. This growth reflects clinical adoption within the UK's regulated system. Understanding this data is key for clinicians monitoring medical cannabis access.
India is ‘treasure trove’ of cannabis genetics, but policy will determine development
India cannabis genetics potential represents a vast untapped resource for new therapeutic cultivars. Policy decisions will determine if this genetic diversity can be developed into clinically relevant medicines. Understanding India's cannabis genetics…
Proposed Rule to Establish Cannabis Research Infrastructure in Missouri
The 2026 cannabis research infrastructure proposal in Missouri aims to establish dedicated marijuana research facilities. This development could enhance clinical research and regulatory oversight. It represents a critical step toward advancing medical…
Glooscap First Nation Nears Key Indigenous Cannabis Regulation Decision
Indigenous cannabis regulation is advancing as Glooscap First Nation approaches a significant decision. This development impacts patient access and clinical frameworks. Clinicians must understand indigenous cannabis regulation to provide informed care.
